AstaReal Co
AstaReal Co., Ltd. is a Japan-headquartered subsidiary of Fuji Chemical Group that produces natural astaxanthin from Haematococcus pluvialis microalgae using proprietary indoor bioreactor cultivation, supplying bulk B2B ingredients and branded retail supplements to global nutraceutical, food, cosmetics, and pet nutrition markets.
- Company typePrivate
- Founded1994
- HeadquartersTokyo, Japan
- Headcount11–50
- GTM typeB2B and B2C
- OfferingHardware or Manufacturing
What AstaReal Co does
AstaReal Co., Ltd. is a Japan-headquartered producer of natural astaxanthin derived from Haematococcus pluvialis microalgae and the primary astaxanthin-focused subsidiary of Fuji Chemical Group. The company's research lineage traces to Uppsala University in 1988; it was commercially established in 1994 upon acquiring BioCaroten AB and achieved the world's first commercial-scale production of natural astaxanthin from Haematococcus pluvialis for human consumption. AstaReal operates a proprietary indoor bioreactor cultivation system that enables year-round, weather-independent production of high-purity astaxanthin, supported by more than 35 years of accumulated research and over 85 clinical studies substantiating safety and efficacy.
The product portfolio spans two channels. The bulk B2B ingredient business supplies dietary supplement, food and beverage, cosmetics, and pet nutrition manufacturers worldwide under the AstaReal® brand in oleoresin (5%, 10%), powder (4%), cold-water-soluble powder (2.5%), and water-soluble emulsion (1%) formats, plus a complementary LutaReal™ lutein emulsion. The retail business markets finished consumer supplements under sub-brands including AstaReal ACT, Astarism, AstaCare, AstaMed MYO, Astavita Sports, Astavita e, Akaimegumi, Astamate (pets), and Astaxin, distributed through approximately 4,500 medical institutions in Japan and direct channels. Production occurs at three facilities in Gustavsberg (Sweden), Moses Lake, Washington (USA), and Japan, with sales offices in Japan, the US, Sweden, Singapore, India, and Australia, complemented by a distributor network across Asia.
AstaReal monetizes through bulk ingredient sales (primary), branded retail supplements, and technology licensing and partnership arrangements. Bulk pricing is quote-based and not publicly disclosed. The company holds FDA GRAS status (2010), Non-GMO Project Verification, Halal, Kosher, GMP, ISO 9001, FSSC 22000, and NSF GMP certifications, and contributed to the U.S. Pharmacopeia monograph for natural astaxanthin. AstaReal is wholly owned by Fuji Chemical Group with no disclosed external institutional investment or public listing.
AstaReal Co firmographics
Firmographics- Name
- AstaReal Co
- Legal name
- AstaReal Co., Ltd.
- Website
- https://astareal.com
- Company type
- Private
- Founded year
- 1994
- Operating status
- Operating
- Headcount range
- 11–50 employees
- Short description
- AstaReal Co., Ltd. is a Japan-headquartered subsidiary of Fuji Chemical Group that produces natural astaxanthin from Haematococcus pluvialis microalgae using proprietary indoor bioreactor cultivation, supplying bulk B2B ingredients and branded retail supplements to global nutraceutical, food, cosmetics, and pet nutrition markets.
- Ownership category
- akta.pro rank
AstaReal Co industry classification
Industry- Product category
- Nutraceutical Ingredients
- NAICS
- Medicinal and Botanical Manufacturing (325411)
- SIC
- Medicinal Chemicals & Botanical Products (2833)
- akta.pro primary industry
- Condition-Specific Bioactives (Glucosamine/Chondroitin, Plant Sterols, Melatonin, Lutein/Zeaxanthin) (AFAJAKAK)
- akta.pro secondary industries
- Pigments & Colorants (Carotenoids, Canthaxanthin) (AFADALAJ), Nutraceuticals & Functional Ingredients for Animal Diets (Probiotics, Omega-3, Joint, GI) (HLAMAHAH)
Keywords
Where AstaReal Co is headquartered
LocationHeadquarters
- HQ city
- Tokyo
- HQ country
- Japan
- HQ region
- Asia
Offices6 records
Markets served
AstaReal Co business model
Business model- GTM type
- B2B and B2C
- Offering type
- Hardware or Manufacturing
- Cost components
- Operations, Supply Chain, Technology or R&D, Personnel, Marketing or Sales
Revenue model
- Bulk Ingredient Sales (B2B): AstaReal supplies natural astaxanthin as a raw material ingredient to dietary supplement, food & beverage, cosmetics, and pet nutrition manufacturers worldwide. This is the primary revenue stream.
- Branded Retail Products: AstaReal markets finished consumer products under the AstaReal brand, including supplements sold through medical institutions and direct-to-consumer channels in Japan.
- Licensing and Technology Partnerships: The company generates revenue through technology licensing arrangements and partnerships that leverage its proprietary production methods.
Go-to-market motion2 records
Distribution channels3 records
Marketing channels5 records
AstaReal Co product offering
Product offeringCore offering
AstaReal cultivates Haematococcus pluvialis microalgae using proprietary indoor bioreactor technology to produce natural astaxanthin, which it sells globally as standardized bulk B2B ingredients (oil, powder, cold-water-soluble powder, water-soluble emulsion, softgels) to dietary supplement, food and beverage, cosmetics, and pet nutrition manufacturers. It also markets a portfolio of branded finished products—including medical nutrition supplements, sports supplements, skincare serums, and pet supplements—sold through medical institutions in Japan, distributors in Europe and Asia, and the Astaxin brand in Europe and China.
Product overview
AstaReal Co is a global leader in natural astaxanthin products, offering a comprehensive portfolio spanning B2B bulk ingredients for manufacturers and B2C retail products for consumers. The bulk product line includes specialized astaxanthin formats: AstaReal® Oil (oleoresin in 5% and 10% concentrations), AstaReal® Powder (4% free-flowing powder), AstaReal® Cold Water Soluble Powder (2.5% CWS format), AstaReal® Water Soluble Emulsion (1% liquid format), LutaReal™ Water Soluble Emulsion (lutein complement), bulk softgel capsules, and Novasta® for Animal nutrition. The retail segment comprises medical nutrition products (AstaReal® ACT, Astarism® facial serum, AstaCare®, AstaMed MYO®) designed for healthcare professionals, and consumer care products (Astavita® Sports, Astavita® e, Akaimegumi, Astamate for pets, and Astaxin). All products are derived from the microalgae Haematococcus pluvialis with over 35 years of research backing and more than 85 clinical studies supporting efficacy and safety.
Differentiator
Problem solved
Functional benefit
Brands
- Astaxin: World's first human dietary supplement containing natural astaxanthin, available in Europe and China.
- Astavita®
- AstaMed
- Astarism®
- AstaCare®
- Novasta®
- LutaReal™
Products and services
- AstaReal® Oil (Oleoresin) Standardized 5% and 10% natural astaxanthin oleoresin extracted from Haematococcus pluvialis algal biomass using solvent-free supercritical CO2 extraction; sold as a B2B ingredient for softgel capsules and functional foods including chocolate and gummies.
- AstaReal® Powder Free-flowing 4% natural astaxanthin powder manufactured with spray-dry technology for heat resistance; supplied to B2B manufacturers for hard capsules, tablets, and functional foods.
- AstaReal® Cold Water Soluble Powder 2.5% cold-water-soluble (CWS) astaxanthin powder that dissolves in cold water within 30 seconds; taste-free, odor-free, with no oil ring formation. Supplied as a B2B ingredient for powder sachets, powder drinks, and functional foods.
- AstaReal® Water Soluble Emulsion 1% water-soluble astaxanthin emulsion with high transparency, clarity, and stability across a wide pH range; supplied as a B2B ingredient for ready-to-drink beverages and functional foods.
- LutaReal™ Water Soluble Emulsion 1% water-soluble lutein emulsion extracted from marigold flower, designed for ready-to-drink products with transparency and clarity; complements astaxanthin in combined health formulations.
- AstaReal® Bulk Softgel Capsules Ready-to-launch private-label softgel capsules containing AstaReal natural astaxanthin, supplied in bulk for manufacturer private-label needs.
- Novasta® for Animal High-performance feed ingredient containing natural astaxanthin whole-algae biomass; supplied to pet food and animal nutrition manufacturers for joint health and mobility support.
- AstaReal® ACT Science-based dietary supplement formulation for optimal health, distributed through approximately 4,500 medical institutions in Japan and additional countries.
- Astarism® Facial serum skin-conditioning product with high astaxanthin concentration designed for skin absorption; endorsed by dermatologists in Japan.
- AstaCare® Advanced dietary supplement combining astaxanthin, ubiquinol COQ10, vitamin D3, tocotrienol, and zinc, marketed for active and healthy lifestyles.
- AstaMed MYO® Medical nutrition dietary supplement originally formulated for the management of sarcopenia, with formulation developed in a joint study with the University of Washington.
- Astavita® Sports Athletic dietary supplement for professional and amateur athletes, endorsed by professional athletes in Japan and Informed Choice certified for anti-doping compliance.
- Astavita® e Daily-life dietary supplement designed to relieve mental and physical fatigue, classified as a 'Foods with Function Claims' product in Japan.
- Akaimegumi Whole-algae dietary supplement providing dietary fiber, unsaturated fatty acids, and minerals including calcium and iron, packaged as a consumer retail product.
- Astamate Pet dietary supplement backed by clinical study supporting muscle health and improved coat shine in companion animals.
- Astaxin World's first natural astaxanthin dietary supplement for healthy and energetic living, marketed under the Astaxin brand in Europe and China.
- Fuji Sakura (Natural Cherry Blossom Flower Extract) Natural cherry blossom flower extract ingredient designed for skin health and beauty-from-within formulations, supplied to B2B customers in the dietary supplement and functional food categories.
Quantifiable outcome
- More than 85 clinical studies supporting product efficacy
- +1 more outcomes
Companies that use AstaReal Co
Customer profileNamed customers2 records
Segments6 records
Ideal customer profiles4 records
AstaReal Co technology and API
TechnologyTechnology focussed No
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Feature1 record
AstaReal Co partnerships and signals
Strategic signalPartnerships
Six partnerships are on record, tiered core and minor.
- Barentz India Pvt. Ltd.coreBarentz India serves as a distributor for AstaReal products in the Indian market, participating at Vitafoods India 2026 to showcase and promote AstaReal natural astaxanthin ingredients to Indian manufacturers.
- GowellcoreGowell serves as a distributor for AstaReal products in Southeast Asia, showcasing products at Vitafoods Asia 2025.
- Primo Trading Co., Ltd.corePrimo Trading serves as a distributor for AstaReal products, participating at Fi Asia trade show.
- Wei Ming Pharmaceutical TaiwancoreWei Ming Pharmaceutical is the exclusive distributor for AstaReal raw material in Taiwan, handling local distribution and sales of natural astaxanthin ingredients.
- Mindly Healthcare Hong KongcoreMindly Healthcare serves as the distribution partner for AstaReal in Hong Kong market.
- VicchiminorVicchi was mentioned as showcasing concept samples alongside AstaReal products, suggesting a collaborative product development or co-marketing relationship.
Scale indicators5 records
Recent moves7 records
Expansion highlights6 records
AstaReal Co competitors and assessment
Company assessmentDirect peers
- Algatechnologies: Algatechnologies (Israel, now part of Solabia group) produces natural astaxanthin from Haematococcus pluvialis in closed-tube and photobioreactor systems. Directly competes in the B2B natural astaxanthin ingredient market with similar product formats.
- Cyanotech Corporation: Cyanotech (NASDAQ: CYAN) produces natural astaxanthin from Haematococcus pluvialis via open-pond cultivation in Hawaii. It is the most direct public competitor to AstaReal in natural astaxanthin bulk production, with overlapping B2B nutraceutical customer base.
- Algalif: Algalif (Iceland) produces high-potency natural astaxanthin from Haematococcus pluvialis using proprietary photobioreactor technology. Direct competitor in premium natural astaxanthin bulk supply for nutraceutical and cosmetic applications.
- BGG (Beijing Gingko Group): BGG produces natural astaxanthin (AstaZine®) along with other botanicals from its Haematococcus pluvialis operations in China. Direct competitor in natural astaxanthin bulk supply, particularly in Asian B2B markets.
Broad incumbents
- Kemin Industries: Kemin is a privately held ingredient manufacturer producing carotenoids and natural antioxidants for human and animal nutrition. Overlaps with AstaReal in supplying natural colorants and antioxidant ingredients to F&B and nutraceutical manufacturers.
- Lonza Group: Lonza is a global contract manufacturer and supplier of nutritional ingredients, including carotenoids and other bioactives. Overlaps with AstaReal at the B2B ingredient customer interface across dietary supplement and functional food manufacturers.
- dsm-firmenich: dsm-firmenich is a global ingredient major producing both synthetic carotenoids (incl. astaxanthin) and a broad portfolio of vitamins, nutraceuticals, and personal care actives. It competes broadly in the same customer RFPs as AstaReal, but at much greater scale and across many categories.
- BASF: BASF is one of the largest producers of synthetic astaxanthin (Lucantin®) for aquaculture and animal feed, and also operates a broad nutrition and health ingredients portfolio. Competes primarily on price in volume channels rather than directly in premium natural astaxanthin.
Emerging players
- ENZYMOTEC: Enzymotec (Israel) develops lipid-based bioactives and krill oil-derived astaxanthin products for the nutraceutical market. Partial overlap with AstaReal in the cognitive, eye-health, and heart-health ingredient space, particularly through phospholipid-formulated astaxanthin delivery.
- Piveg Inc. Piveg produces natural astaxanthin from Haematococcus pluvialis in Spain. A smaller, regional competitor with similar product positioning to AstaReal, primarily serving European nutraceutical and F&B manufacturers.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat5 records
Key risks6 records
Key highlights7 records
Customer concentration
AstaReal Co social profiles
Digital presenceAstaReal Co compliance and trust
Trust signalCompliance9 records
AstaReal Co financial estimates
Financial estimateRevenue estimate
Valuation estimate
AstaReal Co leadership team
Management profileNumber of profiles
Profiles3 records
AstaReal Co subsidiaries and ownership
Company hierarchySubsidiaries5 records
AstaReal Co funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
AstaReal Co M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about AstaReal Co
What does AstaReal Co do?
AstaReal cultivates Haematococcus pluvialis microalgae using proprietary indoor bioreactor technology to produce natural astaxanthin, which it sells globally as standardized bulk B2B ingredients (oil, powder, cold-water-soluble powder, water-soluble emulsion, softgels) to dietary supplement, food and beverage, cosmetics, and pet nutrition manufacturers. It also markets a portfolio of branded finished products—including medical nutrition supplements, sports supplements, skincare serums, and pet supplements—sold through medical institutions in Japan, distributors in Europe and Asia, and the Astaxin brand in Europe and China.
Is AstaReal Co a public or private company?
AstaReal Co is a private company. It is classified as corporate owned and is currently operating.
When was AstaReal Co founded?
AstaReal Co was founded in 1994. It employs 11 to 50 people.
Where is AstaReal Co based?
AstaReal Co is headquartered in Tokyo, Japan, in the Asia region.
How does AstaReal Co make money?
Three revenue lines are on record. Bulk Ingredient Sales (B2B) is the primary driver. The others are branded Retail Products and licensing and Technology Partnerships.
Who are AstaReal Co's main competitors?
Direct peers on record are Algatechnologies, Cyanotech Corporation, Algalif and BGG (Beijing Gingko Group). Broad incumbents are Kemin Industries, Lonza Group, dsm-firmenich and BASF. Emerging players are ENZYMOTEC and Piveg Inc..
Does AstaReal Co have an API?
No public API is recorded for AstaReal Co.
What industry is AstaReal Co in?
AstaReal Co's product category is Nutraceutical Ingredients. Its primary akta.pro industry code is AFAJAKAK, Condition-Specific Bioactives (Glucosamine/Chondroitin, Plant Sterols, Melatonin, Lutein/Zeaxanthin), with a secondary code of AFADALAJ, Pigments & Colorants (Carotenoids, Canthaxanthin). Its NAICS code is 325411 and its SIC code is 2833.